The burden of cardiovascular disease (CVD) among patients with diabetes is substantial.
Individuals with diabetes are at 2-to 4-fold increased risk of cardiovascular events compared …

Patients with chronic or acute liver failure frequently show profound abnormalities in their
hemostatic system. Whereas routine laboratory tests of hemostasis suggest these …

Patients with diabetes mellitus (DM) have accelerated atherosclerosis, which is the main
underlying factor contributing to the high risk of atherothrombotic events in these patients …

Background & Aims Non-alcoholic fatty liver disease (NAFLD) is characterized by increased
risk of cardiovascular events and liver-fibrosis. Both could be explained by a procoagulant …

In the light of growing global epidemic of type 2 diabetes mellitus (T2DM), significant efforts
are made to discover next-generation biomarkers for early detection of the disease. Multiple …

Dietary sources of polyphenols, which are derivatives and/or isomers of flavones,
isoflavones, flavonols, catechins and phenolic acids, possess antioxidant properties and …

Diabetes mellitus (DM) is a chronic metabolic disorder with various complications that poses
a huge worldwide healthcare burden. Wounds in diabetes, especially diabetic foot ulcers …

Hyperactive platelets, in addition to their roles in thrombosis, are also important mediators of
atherogenesis. Antiplatelet drugs are not suitable for use where risk of a cardiovascular …

Aims Reduced aspirin efficacy has been demonstrated in people with Type 2 diabetes.
Because increased platelet reactivity and/or turnover are postulated mechanisms, we …

Diabetes is a metabolic condition with a rising global prevalence and is characterised by
abnormally high blood glucose levels. Cardiovascular disease (CVD) accounts for the …